Dare Bioscience (DARE) vs Karyopharm Therapeutics (KPTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Dare Bioscience (DARE) has outperformed Karyopharm Therapeutics (KPTI) over the past year, losing 64.8% versus a loss of 88.8%. Over five years, DARE leads with a -95.8% price change compared with -99.2% for KPTI. Dare Bioscience is the larger company by market cap ($15.2 million vs $13.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DARE | KPTI |
|---|---|---|
| Share price | $0.7722 | $0.60 |
| Market cap | $15.19M | $13.61M |
| 1-day change | -2.25% | -6.98% |
| YTD return | -59.07% | -91.24% |
| 1-year return | -64.81% | -88.82% |
| 5-year return | -95.81% | -99.23% |
| EPS (TTM) | $-0.71 | $-14.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.78 | $10.99 |
| 52-week low | $0.69 | $0.60 |
| Distance from 52-week high | -79.57% | -94.54% |
| Average volume | 524.37K | 1.70M |
| Shares outstanding | 19.67M | 22.68M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DARE has outperformed KPTI by 24.0 percentage points over the past year.
DARE vs KPTI FAQ
Which is bigger, Dare Bioscience or Karyopharm Therapeutics?
Dare Bioscience (DARE) is larger, with a market capitalization of $15.19M compared with $13.61M for Karyopharm Therapeutics (KPTI).
Which stock has performed better over the past year, DARE or KPTI?
DARE returned -64.81% over the past 12 months, compared with -88.82% for KPTI (price return, excluding dividends). Past performance does not predict future results.
Are Dare Bioscience and Karyopharm Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.